The latest news about Montara
Montara Therapeutics Appoints Dirk Landgraf as Chief Business Officer and Miles Gerson to its Board as it Prepares to Enter the Clinic
September 15, 2026 | San Francisco, CA
Montara Therapeutics Receives Research Grant from The Michael J. Fox Foundation to Advance Parkinson’s Disease Program
June 2, 2026 | San Francisco, CA
Montara Therapeutics to Develop Novel Treatments Using the BrainOnly™ Platform with Grant from The Michael J. Fox Foundation
May 21, 2025 | San Francisco, CA
Montara Therapeutics Closes $20M Oversubscribed Seed Expansion, Appoints Troy Wilson as Chairman of the Board
March 13, 2025 | San Francisco, CA
Endpoints Exclusive: Startup aims to tackle “undruggable” neuro targets with tech from Kevan Shokat’s UCSF lab
July 30, 2024 | San Francisco, CA
